---
$id: https://graph.org.ai/products/commodity/51162711
$type: Product
source: UNSPSC
code: "51162711"
title: "Erdosteine"
class: "51162700"
classTitle: "Decongestants, expectorants, and mucolytics"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Erdosteine

**UNSPSC Code**: 51162711
**Class**: [Decongestants, expectorants, and mucolytics](Decongestants, expectorants, and mucolytics.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a mucolytic agent with the molecular formula C8H11NO4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 76J0853EKA, chemically known as acetic acid, ((2-oxo-2-((tetrahydro-2-oxo-3-thienyl)amino)ethyl)thio)- but more generally known as erdosteine, which bears US NIH Compound Identifier 65632. European Medicines Agency schedules Erdosteine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06595MIG. The term ERDOSTEINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 1, No. 4, 1987, List 27). World Health Organization schedules erdosteine in its Anatomical Therapeutic Chemical (ATC) Classification. ERDOSTEINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule erdosteine under HS 29349990 and SITC 51579. As of Q4 2014, ERDOSTEINE remains US FDA's Preferred Term for this commodity. Erdosteine bears US NLM identifiers UMLS ID C0059506 and NCI Concept Code C61750. SMILES: S1CCC(NC(=O)CSCC(=O)O)C1=O.

